 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | alloCART-19 cell therapy / Fudan University
Enrollment closed, Trial completion date, Trial primary completion date, CAR T-Cell Therapy: Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Mar 15, 2024
P1, N=6, Active, not recruiting, Sponsor: Children's Hospital of Fudan University
Recruiting --> Active, not recruiting | Trial completion date: Jul 2024 --> Jul 2025 | Trial primary completion date: Oct 2023 --> Oct 2024
- | alloCART-19 cell therapy / Fudan University
Trial completion date, Trial primary completion date, CAR T-Cell Therapy: Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Nov 15, 2022
P1, N=6, Recruiting, Sponsor: Children's Hospital of Fudan University
Recruiting --> Active, not recruiting | Trial completion date: Jul 2024 --> Jul 2025 | Trial primary completion date: Oct 2023 --> Oct 2024 Trial completion date: Jul 2022 --> Jul 2024 | Trial primary completion date: Oct 2021 --> Oct 2023
- | alloCART-19 cell therapy / Fudan University
Trial primary completion date, CAR T-Cell Therapy: Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Nov 23, 2020
P1, N=6, Recruiting, Sponsor: Children's Hospital of Fudan University
Trial completion date: Jul 2022 --> Jul 2024 | Trial primary completion date: Oct 2021 --> Oct 2023 Trial primary completion date: Oct 2020 --> Oct 2021
- | alloCART-19 cell therapy / Fudan University
Enrollment open, CAR T-Cell Therapy: Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 17, 2020
P1, N=6, Recruiting, Sponsor: Children's Hospital of Fudan University
Trial primary completion date: Oct 2020 --> Oct 2021 Not yet recruiting --> Recruiting
- | alloCART-19 cell therapy / Fudan University
New P1 trial, CAR T-Cell Therapy: Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Nov 21, 2019
P1, N=6, Not yet recruiting, Sponsor: Children's Hospital of Fudan University